""""""""The transforming growth factor-betas (TGF-betas), which include TGF-betas 1, 2 and 3 in mammals, are a family of multifunctional growth modulators that control an array of functions in animal cells from virtually every lineage. The TGF-betas are able to act as both positive and negative regulators of cell growth, differentiation and transformation depending on the cell type, growth conditions and presence or absence of other peptide growth factors. The TGF-beta response system has been implicated as a tumor suppressor pathway in several organ sytems."""""""" """"""""The most recent efforts have continued to investigate the role of TGF-beta in mouse models of chemically-induced lung tumorigenesis. Expression of the TGF-beta ligands (TGF-betas 1, 2 and 3) and TGF-beta type I and type II receptors (TGF-beta RI and RII) was examined in TGF-beta 1 wildtype (+/+) and TGF-beta 1 heterozygous (+/-) mice. Although the heterozygous mice were shown to be grossly normal, increased cell turnover was demonstrated in the liver and lung. Treatment of these mice with the chemical carcinogen diethylnitrosamine resulted in enhanced tumorigenesis in the liver and lung compared to the TGF-beta 1 wildtype littermates. Immunostaining and in situ hybridization for TGF-beta 1, TGF-beta RI and TGF-beta RII proteins and mRNAs, respectively, showed similar expression in lung adenomas of mice of both TGF-beta 1 genotypes. Tumors in the heterozygous mice did not lose the remaining wild-type TGF-beta 1 allele, indicating that the TGF-beta 1 ligand is a new form of tumor suppressor that shows haploid insufficiency in its ability to protect against tumorigenesis. Future efforts will be aimed at investigating the effects of the TGF-beta 1 genotype on TGF-beta 1 target genes."""""""" """"""""In addition to examining mouse models, we have investigated the regulation of production of proteases, protease inhibitors and extracellular matrix proteins by TGF-beta 1 in human lung cancer cells. To investigate the relationship between plasminogen activator (PA), plasminogen activator inhibitor-1 (PAI-1) and the extracellular matrix in malignant and normal lung epithelial cells and to determine whether malignant lung epithelial cells may be more invasive than normal lung epithelial cells because of differences in expression of these proteins in response to TGF-beta, the regulation of PA, PAI-1, fibronectin, laminin and thrombospondin by TGF-beta 1 in human non-small cell lung cancer (NSCLC) cells was examined and compared with normal human bronchial epithelial (NHBE) cells. TGF-beta 1 caused a persistent increase in expression of the mRNAs for both PA and PAI-1 in NSCLC cells, with the increase in PAI-1 mRNA beginning several hours before that of PA mRNA. By immunoprecipitation analysis, it was shown that TGF-beta 1 also induced a corresponding increase in the amount of PAI-1 protein in these NSCLC cells as well. In contrast, while TGF-beta 1 also increased expression of PAI-1 mRNA in NHBE cells, expression of PA mRNA decreased simultaneously. Treatment of NSCLC cells with TGF-beta 1 resulted in a persistent increase in expression of the mRNAs for fibronectin, laminin and thrombospondin; expression of fibronectin protein also increased after treatment with TGF-beta 1 in these cells. When NHBE cells were similarly cultured in the presence of TGF-_1, expression of fibronectin mRNA also increased in a persistent manner; however, only an early transient increase in the level of the mRNAs for laminin and thrombospondin was detected in these cells. These data show that there is differential regulation of the genes for PA and PAI-1 and the extracellular matrix protein fibronectin in response to TGF-beta 1 not only when NSCLC and NHBE cells are compared, but also when different NSCLC cells are compared with each other. Future efforts will be directed at additional proteases and extracellular matrix proteins to more precisely eulucidate the role of TGF-beta in lung cancer."""""""" The significance of this project is to determine the role of TGF-beta in lung cancer and identify other important negative growth factors that regulate gene expression and cellular proliferation of lung cells. These negative growth factors that slow lung cancer growth may identify targets for development of new chemopreventative agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC000166-07
Application #
6123617
Study Section
Special Emphasis Panel (M)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Ozbun, Laurent L; Martinez, Alfredo; Jakowlew, Sonia B (2005) Differentially expressed nucleolar TGF-beta1 target (DENTT) shows tissue-specific nuclear and cytoplasmic localization and increases TGF-beta1-responsive transcription in primates. Biochim Biophys Acta 1728:163-80
Andreola, Fausto; Calvisi, Diego F; Elizondo, Guillermo et al. (2004) Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion. Hepatology 39:157-66
Bodegas, Elena; Martinez, Alfredo; Ozbun, Laurent L et al. (2004) Depressed adrenomedullin in the embryonic transforming growth factor-beta1 null mouse becomes elevated postnatally. Int J Dev Biol 48:67-70
Kang, Yang; Hebron, Haroun; Ozbun, Laurent et al. (2004) Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis. Mol Carcinog 40:212-31
Zhang, F; Pao, W; Umphress, S et al. (2004) Serum levels of surfactant protein D are increased in mice with lung tumors. Chest 125:109S
Zhang, Feijie; Pao, William; Umphress, Sarah M et al. (2003) Serum levels of surfactant protein D are increased in mice with lung tumors. Cancer Res 63:5889-94
Jakowlew, Sonia B; Mariano, Jennifer (2003) Detection of the transcripts and proteins for the transforming growth factor-beta isoforms and receptors in mouse lung tumorigenesis using in situ hybridization and immunohistochemistry in paraffin-embedded tissue sections. Methods Mol Med 74:145-66
Ozbun, Laurent L; Martinez, Alfredo; Angdisen, Jerry et al. (2003) Differentially expressed nucleolar TGF-beta1 target (DENTT) in mouse development. Dev Dyn 226:491-511
Farley, J; Gray, K; Nycum, L et al. (2000) Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Gynecol Oncol 78:113-22
Jakowlew, S B; Zakowicz, H; Moody, T W (2000) Retinoic acid down-regulates VPAC(1) receptors and TGF-beta 3 but up-regulates TGF-beta 2 in lung cancer cells. Peptides 21:1831-7

Showing the most recent 10 out of 13 publications